Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Stock

Showing results (161-170 of 171) with videos related to

Pageof 18
Sort By:
European Heart Journal|October 19, 2017
2017 Update of ESC/EAS Task Force on practical clinical guidance for proprotein convertase subtilisin/kexin type 9 inhibition in patients with atherosclerotic cardiovascular disease or in familial hypercholesterolaemiaUlf Landmesser, M John Chapman, Jane K Stock, et al.
European Heart Journal|August 29, 2022
Lipoprotein(a) in atherosclerotic cardiovascular disease and aortic stenosis: a European Atherosclerosis Society consensus statementFlorian Kronenberg, Samia Mora, Erik S G Stroes, et al.
European Heart Journal|September 2, 2021
Triglyceride-rich lipoproteins and their remnants: metabolic insights, role in atherosclerotic cardiovascular disease, and emerging therapeutic strategies-a consensus statement from the European Atherosclerosis SocietyHenry N Ginsberg, Chris J Packard, M John Chapman, et al.
Cell Genomics|June 28, 2024
Evolutionary and biomedical implications of sex differences in the primate brain transcriptomeAlex R DeCasien, Kenneth L Chiou, Camille Testard, et al.
Journal of Medicinal Chemistry|April 8, 2015
Structure-Based Design of Potent and Selective Inhibitors of the Metabolic Kinase PFKFB3Scott Boyd, Joanna L Brookfield, Susan E Critchlow, et al.
European Heart Journal|April 27, 2017
Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus PanelBrian A Ference, Henry N Ginsberg, Ian Graham, et al.
European Heart Journal|May 3, 2018
Adverse effects of statin therapy: perception vs. the evidence - focus on glucose homeostasis, cognitive, renal and hepatic function, haemorrhagic stroke and cataractFrançois Mach, Kausik K Ray, Olov Wiklund, et al.
Science Advances|April 13, 2022
Social connections predict brain structure in a multidimensional free-ranging primate societyCamille Testard, Lauren J N Brent, Jesper Andersson, et al.
Nature Neuroscience|November 24, 2022
Multiregion transcriptomic profiling of the primate brain reveals signatures of aging and the social environmentKenneth L Chiou, Alex R DeCasien, Katherina P Rees, et al.
Nature Reviews. Clinical Oncology|June 2, 2016
Clinical development of new drug-radiotherapy combinationsRicky A Sharma, Ruth Plummer, Julie K Stock, et al.
Pageof 18

Showing results (161-170 of 171) with videos related to

Sort By:
Pageof 18
European Heart Journal|October 19, 2017
2017 Update of ESC/EAS Task Force on practical clinical guidance for proprotein convertase subtilisin/kexin type 9 inhibition in patients with atherosclerotic cardiovascular disease or in familial hypercholesterolaemiaUlf Landmesser, M John Chapman, Jane K Stock, et al.
European Heart Journal|August 29, 2022
Lipoprotein(a) in atherosclerotic cardiovascular disease and aortic stenosis: a European Atherosclerosis Society consensus statementFlorian Kronenberg, Samia Mora, Erik S G Stroes, et al.
European Heart Journal|September 2, 2021
Triglyceride-rich lipoproteins and their remnants: metabolic insights, role in atherosclerotic cardiovascular disease, and emerging therapeutic strategies-a consensus statement from the European Atherosclerosis SocietyHenry N Ginsberg, Chris J Packard, M John Chapman, et al.
Cell Genomics|June 28, 2024
Evolutionary and biomedical implications of sex differences in the primate brain transcriptomeAlex R DeCasien, Kenneth L Chiou, Camille Testard, et al.
Journal of Medicinal Chemistry|April 8, 2015
Structure-Based Design of Potent and Selective Inhibitors of the Metabolic Kinase PFKFB3Scott Boyd, Joanna L Brookfield, Susan E Critchlow, et al.
European Heart Journal|April 27, 2017
Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus PanelBrian A Ference, Henry N Ginsberg, Ian Graham, et al.
European Heart Journal|May 3, 2018
Adverse effects of statin therapy: perception vs. the evidence - focus on glucose homeostasis, cognitive, renal and hepatic function, haemorrhagic stroke and cataractFrançois Mach, Kausik K Ray, Olov Wiklund, et al.
Science Advances|April 13, 2022
Social connections predict brain structure in a multidimensional free-ranging primate societyCamille Testard, Lauren J N Brent, Jesper Andersson, et al.
Nature Neuroscience|November 24, 2022
Multiregion transcriptomic profiling of the primate brain reveals signatures of aging and the social environmentKenneth L Chiou, Alex R DeCasien, Katherina P Rees, et al.
Nature Reviews. Clinical Oncology|June 2, 2016
Clinical development of new drug-radiotherapy combinationsRicky A Sharma, Ruth Plummer, Julie K Stock, et al.
Pageof 18